Ocelot Bio
San Diego
About Ocelot Bio
Ocelot Bio brings new treatment options to patients with severe liver disease. It researches and discovers medicines that help in the treatment of hepatorenal syndrome, a complication of severe liver disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $39.0M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Jul 2023)
- Website: ocelotbio.com
- Phone: +1 530 320 7230
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/ocelot-bio-84476 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.